Joyce Stellabott

Discovery of [(2<i>R</i>,5<i>R</i>)‐5‐{[(5‐Fluoropyridin‐2‐yl)oxy]methyl}‐2‐methylpiperidin‐1‐yl][5‐methyl‐2‐(pyrimidin‐2‐yl)phenyl]methanone (MK‐6096): A Dual Orexin Receptor Antagonist with Potent Sleep‐Promoting Properties

Paul J. Coleman, John D. Schreier, Christopher D. Cox et al. · ChemMedChem · 2012 · 124 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Discovery of 5′′‐Chloro‐<i>N</i>‐[(5,6‐dimethoxypyridin‐2‐yl)methyl]‐2,2′:5′,3′′‐terpyridine‐3′‐carboxamide (MK‐1064): A Selective Orexin 2 Receptor Antagonist (2‐SORA) for the Treatment of Insomnia

Anthony J. Roecker, Swati P. Mercer, John D. Schreier et al. · ChemMedChem · 2013 · 68 citations

Medicine, Medicinal Chemistry, Pharmacology +12

Understanding the process-product-performance interplay of spray dried drug-polymer systems through complete structural and chemical characterization of single spray dried particles

Sadegh Poozesh, Nico Setiawan, Freddy Arce et al. · Powder Technology · 2017 · 41 citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutics +17

Discovery of MK-3697: A selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia

Anthony J. Roecker, Thomas S. Reger, M. Christa Mattern et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 29 citations · Full text

Medicine, Neuroscience, Pharmacology +12

Comparing Dog and Human Intestinal Fluids: Implications on Solubility and Biopharmaceutical Risk Assessment

Paul L. Walsh, Joyce Stellabott, Rebecca Nofsinger et al. · AAPS PharmSciTech · 2016 · 15 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +14